| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (Methicillin-susceptible) |
0.06 |
0.125 |
0.016 － 0.125 |
Retapamulin  |
596 |
| Staphylococcus aureus (Methicillin-susceptible) |
0.06 |
0.125 |
0.03 － 0.125 |
Retapamulin |
596 |
| Staphylococcus aureus (methicillin-susceptible) |
0.06 |
0.125 |
0.06 － 0.125 |
Faropenem |
317 |
| Staphylococcus aureus (methicillin-susceptible) |
0.06 |
0.13 |
? － ? |
Dalbavancin |
1111 |
| Staphylococcus aureus (methicillin-susceptible) |
0.06 |
4 |
≤0.016 － 8 |
Gatifloxacin (Tequin) |
207 |
| Staphylococcus aureus (methicillin-susceptible) |
0.063 |
0.063 |
0.032 － 0.125 |
S-4661 |
952 |
| Staphylococcus aureus (methicillin-susceptible) |
>=0.063 |
≥0.063 |
≥0.063 － ? |
Imipenem |
56 |
| Staphylococcus aureus (methicillin-susceptible) |
≤0.063 |
≤0.063 |
≤0.063 － ? |
L-036 |
56 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.12 |
0.015 － 0.5 |
Tigecycline (GAR-936, Tigacyl) |
475 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.12 |
0.03 － 0.12 |
Retapamulin |
604 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.12 |
≤0.06 － 0.12 |
Clindamycin (Cleocin) |
396 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.12 |
0.06 － 0.25 |
Sparfloxacin (AT-4140, Zagam) |
117 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.12 |
0.06 － 8 |
Minocycline (Minocycline hydrochloride, Minocin) |
604 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.12 |
0.06 － >8 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
73 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.12 |
0.06 － >16 |
Clindamycin (Cleocin) |
604 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.25 |
0.06 － 0.25 |
NB2001 |
186 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.25 |
0.06 － 0.5 |
Gatifloxacin (Tequin) |
130 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.25 |
0.06 － 0.5 |
Gatifloxacin (Tequin) |
443 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.25 |
≤0.06 － 2 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
186 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.25 |
0.06 － >16 |
Levofloxacin (Levaquin, Quixin) |
12 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.25 |
<0.12 － 0.25 |
Quinupristin/Dalfopristin (Synercid) |
1060 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.25 |
0.12 － 0.25 |
Tigecycline (GAR-936, Tigacyl) |
311 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.25 |
0.12 － 0.25 |
Tigecycline (GAR-936, Tigacyl) |
214 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.25 |
≤0.12 － 16 |
Clindamycin (Cleocin) |
371 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
0.25 |
? － ? |
Tigecycline (GAR-936, Tigacyl) |
36 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
1 |
0.06 － 16 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
55 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
4 |
≤0.06 － >=64 |
Levofloxacin (Levaquin, Quixin) |
475 |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
8 |
≤0.12 － >64 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
371 |